Desmoid tumor study: just watching may be enough
NCT ID NCT04281381
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 100 people with desmoid-type fibromatosis, a rare tumor, for 12 months without giving any treatment. The goal is to see how often the tumors stay stable or shrink on their own. Participants get regular MRI or CT scans to track changes. The results could help doctors decide when to treat and when to simply watch.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that many desmoid tumors grow slowly or stay stable, helping doctors avoid unnecessary treatments.
- What could go wrong
- This is an observational study with no treatment given, so it won't directly help participants. It may also find that some tumors grow quickly, requiring intervention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOID FIBROMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cancer drug shows promise in slowing rare tumor growth
- Electric pulses plus chemo aimed at rare tumor, but study pulled
- No-Chemo embolization tackles rare desmoid tumors
- Promising drug may shrink rare tumors in kids without surgery
- Immunotherapy duo takes on rare tumors
- Massive childhood cancer registry launches to unlock better treatments